Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem

Authors
Giti Ozgoli 1
Zohre Sheikhan 1
Mahrokh Dolatian 1
Masumeh Simbar 1
Maryam Bakhtyari 2
Maliheh Nasiri 3
1 The Research Centre for Safe Motherhood, Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Clinical Psychology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Biostatics, Faculty of Paramedic, Shahid Beheshti University, Tehran, Iran
Abstract
Background: Sexual affairs are one of the physiological needs affecting human health. Sexual functioning disorders can reduce individual’s capabilities and creativities. Sexual relations are in the center of women’s quality of life. The most important family planning is to prevent unintended pregnancies. Injectable contraceptives protect women exposed to many complications and mortality due to unintended pregnancies, with tolerable effects on other aspects of women’s life. An important aspect of women’s life is sexual health. This study aimed to compare sexual function of women using DMPA with women using Cyclofem presented to health centers affiliated to Shahid Beheshti University of Medical Sciences in Tehran, Iran in 2013. Methods: This descriptive-comparative study was conducted on 240 women in health centers in Tehran, Iran. They were selected by multistage sampling. The data was collected using a questionnaire completed by interviewing. The questionnaire had 2 parts, demographic characteristic section and Female Sexual Function Index (FSFI). Data was analyzed by descriptive statistics, independent T-test, U-test, Chi-square, Fisher exact test. The p-value less than 0.05 were applied for all statistical tests as significance level. Results: The difference in sexual function between Cyclofem and DMPA groups was insignificant, but in terms of sexual desire in DMPA users better than and sexual pain them less than in Cyclofem users, the difference between the groups was significant (p<0.05). Conclusion: In introducing hormonal contraceptive methods, health workers should emphasize their adverse effects on sexual function. Women who use Cyclofem and DMPA should be aware that they may experience some changes in libido and sexual pain.
Keywords
Cyclofem
DMPA
Sexual dysfunction
  1. Gonzalez M, Viafara G, Caba F, Molina E. Sexual function, menopause and hormone replacement therapy (HRT). Maturitas. 2004;48(4):411-20.
  2. Korda JB. [Female sexual dysfunction]. Urologe A. 2008;47(1):77-89. German.
  3. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654-8.
  4. Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. Eur Urol. 2005;47(3):366-74.
  5. Panzer C, Wise S, Fantini G, Kang D, Munarriz R, Guay A, et al. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med. 2006;3(1):104-13.
  6. Foroutan SK, Jadid Milani M. Prevalence of sexual dysfunction in patients referred to the Family Justice Center. Daneshvar J. 2008;16(78):39-44.
  7. Nik-Azin A, Nainian MR, Zamani M, Bavojdan MR, Bavojdan MR, Motlagh MJ. Evaluation of sexual function, quality of life, and mental and physical health in pregnant women. J Family Reprod Health. 2013;7(4):171-6.
  8. Bolhari J, Ramezanzadeh F, Abedininia N, Naghizadeh MM, Pahlavani H, Saberi M. The survey of divorce incidence in divorce applicants in Tehran. J Family Reprod Health. 2012;6(3):129-37.
  9. Ojanlatva A, Makinen J, Helenius H, Korkeila K, Sundell J, Rautava P. Sexual activity and perceived health among Finnish middle-aged women. Health Qual Life Outcomes. 2006;4:29.
  10. Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health. 2009;12(5):763-72.
  11. Sitruk-Ware R, Nath A, Mishell DR Jr. Contraception technology: past, present and future. Contraception. 2013;87(3):319-30.
  12. Morroni C, Myer L, Moss M, Hoffman M. Preferences between injectable contraceptive methods among South African women. Contraception. 2006;73(6):598-601.
  13. Canto de Cetina TE, Luna MO, Cetina Canto JA, Bassol S. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. Contraception. 2004;69(2):115-9.
  14. Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception. 2006;73(6):584-7.
  15. Guazzelli CA, Jacobucci MS, Barbieri M, Araujo FF, Moron AF. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects. Contraception. 2007;76(1):45-8.
  16. Bortolotti de Mello Jacobucci MS, Guazzelli CA, Barbieri M, Araujo FF, Moron AF. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year. Contraception. 2006;73(6):594-7.
  17. Berek JS. Berek & Novak’s Gynecology. 15th ed. Philadelphia: Lippincott Williams & Wilkins; c2012. Chapter 11, Sexuality, sexual dysfunction and sexual assault; p. 270-305.
  18. Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Schootman M, Peipert JF, Cottler LB, et al. Type of contraception method used at last intercourse and associations with health risk behaviors among US adolescents. Contraception. 2010;82(6):549-55.
  19. Ruminjo JK, Sekadde-Kigondu CB, Karanja JG, Rivera R, Nasution M, Nutley T. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya. Contraception. 2005;72(2):138-45.
  20. Wallwiener M, Wallwiener LM, Seeger H, Mueck AO, Zipfel S, Bitzer J, et al. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception. 2010;82(2):155-9.
  21. Davis AR, Castano PM. Oral contraceptives and libido in women. Annu Rev Sex Res. 2004;15:297-320.
  22. Witting K, Santtila P, Jern P, Varjonen M, Wager I, Hoglund M, et al. Evaluation of the female sexual function index in a population based sample from Finland. Arch Sex Behav. 2008;37(6):912-24.
  23. Schaffir J. Hormonal contraception and sexual desire: a critical review. J Sex Marital Ther. 2006;32(4):305-14.
  24. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51-8.
  25. Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74(3):220-3.
  26. Hubacher D, Lopez L, Steiner MJ, Dorflinger L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception. 2009;80(2):113-8.
  27. Gold MA, Bachrach LK. Contraceptive use in teens: a threat to bone health? J Adolesc Health. 2004;35(6):427-9.
  28. Schaffir JA, Isley MM, Woodward M. Oral contraceptives vs injectable progestin in their effect on sexual behavior. Am J Obstet Gynecol. 2010;203(6):545.e1-5.
  29. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
  30. Hussein M, Mahran DG, Farouk OA, El-Assal MA, Fathallah MM, Romih MS. Bone mineral density in women of a low socioeconomic level using DMPA for contraception in rural Upper Egypt. Int J Gynaecol Obstet. 2010;110(1):31-4.
  31. Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin North Am. 2003;26(3):673-82.
  32. Nijland EA, Weijmar Schultz WC, Nathorst-Boos J, Helmond FA, Van Lunsen RH, Palacios S, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med. 2008;5(3):646-56.
  33. van Lunsen RH, Laan E. Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause. 2004;11(6 Pt 2):741-8.
  34. Modelska K, Litwack S, Ewing SK, Yaffe K. Endogenous estrogen levels affect sexual function in elderly post-menopausal women. Maturitas. 2004;49(2):124-33.
  35. Barrientos JE, Paez D. Psychosocial variables of sexual satisfaction in Chile. J Sex Marital Ther. 2006;32(5):351-68.
  36. Auslander BA, Rosenthal SL, Fortenberry JD, Biro FM, Bernstein DI, Zimet GD. Predictors of sexual satisfaction in an adolescent and college population. J Pediatr Adolesc Gynecol. 2007;20(1):25-8.
  37. Asghari Roodsari A, Khademi A, Akbari D, Hamed E, Tabatabaiifar SL, Alleyassin A. Female sexual dysfunction in married medical students. Mcgill J Med. 2005;8(2):104-8.
  38. Wiebe ER, Brotto LA, MacKay J. Characteristics of women who experience mood and sexual side effects with use of hormonal contraception. J Obstet Gynaecol Can. 2011;33(12):1234-40.
  39. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354(14):1497-506.
  40. Aladag N, Filiz M, Topsever P, Apaydin P, Gorpelioglu S. Satisfaction among women: differences between current users of barrier (male condom) and non-barrier methods. Eur J Contracept Reprod Health Care. 2006;11(2):81-8.
Journal of Reproduction & Infertility
Volume 16, Issue 2
Spring 2015
Pages 102-108